Abstract
The present disclosure provides, in various embodiments, stable injectable particle suspensions of therapeutic biologics and hyaluronan degrading agents that permit administration without the need for resuspension. In particular, the compositions disclosed herein are highly concentrated, low-volume injectable particle suspensions that increase bioavailability of therapeutic biologics.
Full Text
What is claimed is:
The present disclosure provides, in various embodiments, stable injectable particle suspensions of therapeutic biologics and hyaluronan degrading agents that permit administration without the need for resuspension. In particular, the compositions disclosed herein are highly concentrated, low-volume injectable particle suspensions that increase bioavailability of therapeutic biologics.
Timeline
Filed
06/16/2026Published
10/01/2026Granted
Not AvailableIPC Codes(4)
A61K 38/47:acting on glycosyl compounds (3.2), e.g. cellulases, lactases
A61K 38/38:Albumins
C07K 16/28:against receptors, cell surface antigens or cell surface determinants